<SEC-DOCUMENT>0001193125-22-034912-index.html : 20220211
<SEC-HEADER>0001193125-22-034912.hdr.sgml : 20220211
<ACCEPTANCE-DATETIME>20220210204454
ACCESSION NUMBER:		0001193125-22-034912
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20220211
DATE AS OF CHANGE:		20220210
GROUP MEMBERS:		VERSANT AFFILIATES FUND V, L.P.
GROUP MEMBERS:		VERSANT OPHTHALMIC AFFILIATES FUND I, L.P.
GROUP MEMBERS:		VERSANT VENTURE CAPITAL V (CANADA) LP
GROUP MEMBERS:		VERSANT VENTURE CAPITAL V, L.P.
GROUP MEMBERS:		VERSANT VENTURES V (CANADA), L.P.
GROUP MEMBERS:		VERSANT VENTURES V GP-GP (CANADA), INC.

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aprea Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001781983
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-91159
		FILM NUMBER:		22616239

	BUSINESS ADDRESS:	
		STREET 1:		535 BOYLSTON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		6095104718

	MAIL ADDRESS:	
		STREET 1:		535 BOYLSTON STREET
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Versant Ventures V, LLC
		CENTRAL INDEX KEY:			0001619298
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		ONE SANSOME STREET
		STREET 2:		SUITE 3630
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		650-233-2215

	MAIL ADDRESS:	
		STREET 1:		ONE SANSOME STREET
		STREET 2:		SUITE 3630
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>d258346dsc13ga.htm
<DESCRIPTION>SC 13G/A
<TEXT>
Document 1 - file: d258346dsc13ga.htm

</DOCUMENT>
</SEC-DOCUMENT>